{"prompt": "['Cara Therapeutics, Inc.', 'Difelikefalin (IV CR845)', 'CR845-CLIN3102', 'Clinical Study Report - Double-blind Phase', 'Cara Therapeutics Inc.', 'Confidential', 'Page 92 of 92', 'CR845-CLIN3102', 'model and the results combined using SAS proc MIANALYZE. Logistic model', 'covariates will include treatment, baseline NRS score, use of prior anti-itch medication,', 'and presence of select medical conditions. As with the MI, should convergence issues', 'occur due to small cell sizes, the appropriate categorical covariate(s) will be dropped as', 'necessary.', 'Should a sample size increase occur, the above process will be implemented completely', 'independently among subjects contributing the interim results and those following the', 'interim analysis.', 'For the tipping point analysis, a shift parameter will be applied to only subjects in the', 'active group, running from 0 to 5 points in 0.25-point increments or until the conclusions', 'of the analysis \"tip\" and the results are no longer significant. This analysis will not be', 'performed should the initial primary results fail to achieve significance.', '21 December 2017', 'Version 1.0', 'CONFIDENTIAL', 'Page 94 of 95']\n\n###\n\n", "completion": "END"}